New Zealand markets open in 5 minutes

MRNA Jan 2023 300.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.4200+0.2200 (+10.00%)
As of 03:17PM EDT. Market open.
Full screen
Previous close2.2000
Open2.2000
Bid2.1800
Ask2.4500
Strike300.00
Expiry date2023-01-20
Day's range2.2000 - 2.4200
Contract rangeN/A
Volume21
Open interest6.71k
  • Zacks

    Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response

    Pfizer (PFE) and partner BioNTech's (BNTX) Omicron-specific COVID vaccine candidates achieves a higher immune response against the variant in a phase II/III study.

  • Motley Fool

    Could This Be Moderna's Ticket to Long-Term Success?

    Moderna (NASDAQ: MRNA) waited a long time to reach this important moment: the authorization of its vaccine in infants and children. This month, the FDA authorized the vaccine for both teens and children ages six months and older, and vaccine rollout has begun for the youngest group. Could this new authorization be Moderna's ticket to long-term success?

  • Motley Fool

    2 Biotech Stocks That Could Make You Richer

    The biotech industry hasn't performed well this year, even by the standards of the struggling stock market. The SPDR S&P Biotech ETF -- an industry benchmark -- is down by 36% year to date. The good news is that there are still plenty of great biotech stocks that could be solid long-term picks.